This Rx Road Map provides a detailed guide for the use of vorasidenib in patients with astrocytoma and oligodendroglioma.

Linda Casey, RN, shares essential strategies for oncology nurses to protect vulnerable patients from the clinical risks of wildfire smoke exposure. As Canadian wildfire smoke blanketed the tri-state ...

Patients receiving subcutaneous daratumumab have less chair time and premedication than those receiving IV formulation, says Heather Wenberg, BSN, RN, OCN. The subcutaneous formulation of daratumumab ...

Cancer remains one of the most significant public health challenges globally, accounting for nearly 10 million deaths each year. 1 Still, only a handful of cancer types have recommended routine ...

FDA expanded pembrolizumab and enfortumab vedotin-ejfv for all surgery-eligible adults with muscle-invasive bladder cancer following positive trial data. The Food and Drug Administration (FDA) has ...

Please check back later for more content.

This is the first in a 3-part series about nurses as advocates within healthcare. Many nurses think of advocacy as the most important role we play in patient care. We need to remember that to best ...

“New oncology therapies offer nurses a new challenge, and we will accept this challenge.” It is an exciting time to be an oncology nurse. Over the past several decades, cancer treatment has ...

An oncology research nurse balances patient care with rigorous data collection, emphasizing communication and collaboration to advance cancer research. Oncology research nurses play an integral role ...

There is not yet enough research to support a medical stance on fasting during cancer treatment despite growing patient interest in the practice. How is your appetite?” you ask. Your patient receiving ...

Chasity Washington MPH, CHES | Authors | Oncology Nursing News connects oncology nurses and APPs with updates on therapy advances, side effect management, and patient-centered cancer care.

The FDA has granted traditional approval to selpercatinib for adult and pediatric patients with RET fusion-positive solid tumors post-progression. The Food and Drug Administration (FDA) has converted ...